Here we explored targeting and inhibiting the enzyme ATP-citrate lyase (ACLY) to determine its effects on relevant disease parameters in vitro and in a conditional Pkd1 knockout mouse model of ADPKD. Here, ACLY is linked to autosomal dominant polycystic kidney disease.